신경혈관 기기 시장 규모, 점유율, 동향 분석 보고서 : 디바이스별, 치료 용도별, 규모별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Neurovascular Devices Market Size, Share & Trends Analysis Report By Device (Neurothrombectomy Devices, Support Devices), By Therapeutic Application (Stroke, Cerebral Artery Stenosis), By Size, By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,609,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,950 ￦ 10,055,000

Printable PDF (5-User License)

PDF 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,950 ￦ 12,949,000

Printable PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

신경혈관 기기 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 전 세계 신경혈관 기기 시장 규모는 2025-2030년 동안 CAGR 6.01%를 기록하여 2030년에는 45억 3,000만 달러에 달할 것으로 예상됩니다.

뇌졸중, 뇌동맥류, 뇌동맥 협착증과 같은 신경질환의 유병률 증가로 신경혈관 기기 시장의 성장을 촉진하고 있습니다. 세계뇌졸중기구(WSO)에 따르면 2022년에는 연간 1,220만 명 이상의 뇌졸중 환자가 새로 발생할 것으로 예상하고 있습니다.

25세 이상 성인 4명 중 1명은 평생 동안 뇌졸중을 앓게 됩니다. 또한 허혈성 뇌졸중은 매년 약 760만 명이 새롭게 발병합니다. 전 세계적으로 발생하는 뇌졸중의 약 62.0%가 허혈성 뇌졸중이며, 매년 120만 건 이상의 지주막하 출혈이 새롭게 발생하고 있습니다. 이는 신경혈관 기기에 대한 큰 수요가 존재하며, 신경혈관 기기 시장 확대의 원동력이 되고 있다는 것을 수치로 보여주고 있습니다.

선진국과 신흥국 모두에서 뇌동맥류 유병률이 증가하면서 기술적으로 진보된 제품을 시장에 출시하는 원동력이 되고 있습니다. 두개내 동맥류의 주요 치료 기술로는 외과적 클리핑, 혈관 내 코일링, 유량분배기 등이 있습니다. 시장 진입 기업들은 항상 기술적으로 진보된 제품을 시장에 출시하기 위해 노력하고 있습니다.

예를 들어, 2021년 9월 Medtronic plc는 Rist 079 Access Radial Guide Catheter와 Access Rist Radial Selective Catheter로 구성된 요골동맥 접근 포트폴리오에 대한 CE 마크 승인을 발표했습니다. 또한 2022년 3월 Micro Port Scientific Company는 Hyperflex Balloon Catheter가 일본 의약품의료기기종합기구(PMDA)로부터 등록 승인을 받았다고 발표했습니다.

수술 후 불편함 감소와 빠른 회복은 최소침습 수술의 활용을 확대하고 이 분야의 연구 개발을 촉진하는 요인입니다. 혈관 내 코일링은 뇌동맥류 치료를 위해 임상의들이 자주 제안하는 최소침습 수술 중 하나입니다. 하이드로코일(MicroVention, 미국 캘리포니아 주 태스틴)은 베어 플래티넘 코일과 비교하여 재발률이 낮고, 더 복잡한 동맥류 구조의 치료를 가능하게 했습니다. 결과적으로 최소침습적 치료에 대한 수요 증가는 신경혈관 기기 시장의 성장을 뒷받침하고 있습니다.

신경혈관 기기 시장 보고서 하이라이트

• 뇌색전 및 동맥류 코일링 장치는 2024년 약 36.02%의 가장 큰 시장 점유율을 차지했습니다. 코일 색전술은 동맥류 치료를 위한 최소침습적 시술로, 재료가 주머니를 닫아 출혈 위험을 줄입니다.
• 뇌졸중은 고혈압, 뇌졸중 및 기타 신경 질환의 유병률 증가 등의 요인으로 인해 2024년 약 56.86%의 가장 큰 시장 점유율을 차지했습니다.
• 0.021 인치는 2024년에 약 27.08%의 가장 큰 시장 점유율을 차지했습니다. 이 부문의 성장은 0.021 인치 장치가 제공하는 다양한 이점과 다양한 제품 출시 및 제품 승인에 기인합니다.
• 병원은 2024년 약 70.79%로 가장 큰 시장 점유율을 차지했습니다. 이 부문의 성장은 허혈성 및 출혈성 뇌졸중, 뇌동맥류, 외상성 뇌손상(TBI), 동정맥 기형(AVM)과 같은 신경혈관 질환을 앓고 있는 환자의 증가가 주요 원인으로 추정됩니다.
• 북미 신경혈관 기기는 Penumbra, Inc., Stryker Corporation, Johnson & Johnson, Merit medical systems, Inc.와 같은 주요 제조업체의 존재로 인해 2024년에는 27.62%의 점유율로 시장을 장악했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 신경혈관 기기 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 신경혈관 기기 분석 툴
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 신경혈관 기기 시장 : 부문 분석, 디바이스별, 2018-2030년(100만 달러와 수량 단위)

• 정의와 범위
• 디바이스 시장 점유율 분석, 2024년과 2030년
• 세계의 신경혈관 기기 시장, 디바이스별, 2018-2030년
• 시장 규모와 예측과 동향 분석, 2018-2030년

제5장 신경혈관 기기 시장 : 부문 분석, 치료 용도별, 2018-2030년(100만 달러)

• 정의와 범위
• 치료 용도 시장 점유율 분석, 2024년과 2030년
• 세계의 신경혈관 기기 시장, 치료 용도별, 2018-2030년
• 시장 규모와 예측과 동향 분석, 2018-2030년

제6장 신경혈관 기기 시장 : 부문 분석, 규모별, 2018-2030년(100만 달러)

• 정의와 범위
• 규모 시장 점유율 분석, 2024년과 2030년
• 세계의 신경혈관 기기 시장, 규모별, 2018-2030년
• 시장 규모와 예측과 동향 분석, 2018-2030년

제7장 신경혈관 기기 시장 : 부문 분석, 최종 용도별, 2018-2030년(100만 달러)

• 정의와 범위
• 최종 용도 시장 점유율 분석, 2024년과 2030년
• 세계의 신경혈관 기기 시장, 최종 용도별, 2018-2030년
• 시장 규모와 예측과 동향 분석, 2018-2030년

제8장 신경혈관 기기 시장 : 지역별, 추정·동향 분석

• 지역 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 멕시코
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제9장 경쟁 상황

• 시장 진출 기업 분류
• 주요 시장 진출 기업의 최근 동향과 영향 분석
• 기업 시장 점유율 분석, 2024년
• 주요 기업 개요
  • Medtronic
  • Stryker Corporation
  • Terumo Corporation
  • Penumbra, Inc.
  • Johnson & Johnson Services, Inc.
  • Integra LifeSciences Corporation
  • Acandis GmbH
  • Spiegelberg GmbH &Co. KG
  • MicroPort Scientific Corporation
  • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

ksm

영문 목차

영문목차

Neurovascular Devices Market Growth & Trends:

The global neurovascular devices market size is expected to reach USD 4.53 billion by 2030, registering a CAGR of 6.01% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of neurological illnesses such as stroke, brain aneurysm, and cerebral artery stenosis is driving growth of the neurovascular devices market. According to the World Stroke Organization (WSO), in 2022, there will be more than 12.2 million new strokes per year.

One in every four adults above the age of 25 will suffer a stroke throughout their lifetime. In addition, nearly 7.6 million new ischemic strokes occur each year. Around 62.0% of all incident strokes worldwide are ischemic strokes, with more than 1.2 million new subarachnoid hemorrhages occurring each year. As a result, the figures show that there is a significant demand for the neurovascular devices, which is driving neurovascular device market expansion.

The rising prevalence of brain aneurysms in both developed and developing countries is driving the introduction of technologically advanced products to the market. Some significant therapeutic techniques for an intracranial aneurysm include surgical clipping, endovascular coiling, and flow diverters. Market participants are constantly working to introduce technologically advanced products to the market.

For instance, in September 2021, Medtronic plc. announced the CE Mark clearance of its radial artery access portfolio, which comprises the Rist 079 Access Radial Guide Catheter and the Access Rist Radial Selective Catheter. Furthermore, in March 2022, Micro Port Scientific Company announced that its Hyper flex Balloon Catheter has received registration approval from the Japan Pharmaceuticals and Medical Devices Agency (PMDA).

Reduced postoperative discomfort and faster recovery are the factors expanding use of the minimally invasive operations and fueling R&D in this field. Endovascular coiling is a minimally invasive surgery that is frequently suggested by the clinicians for the treatment of cerebral aneurysms. Hydro Coils (MicroVention, Tustin, California, USA) have permitted the treatment of more complex aneurysmal structures with reduced recurrence rates as compared to bare-platinum coils. As a result, increased demand for the minimally invasive procedures is supporting neurovascular device market expansion.

Neurovascular Devices Market Report Highlights:

• Cerebral embolization and aneurysm coiling devices held the largest market share of around 36.02% in 2024. Coil embolization is a minimally invasive procedure for the treatment of aneurysms, wherein, the material closes the sac and reduces the risk of bleeding.
• Stroke held the largest market share of around 56.86% in 2024, owing to the factors such as increasing prevalence of hypertension, stroke, and other neurological disorders.
• 0.021" held the largest market share of around 27.08% in 2024. Segment growth can be attributed to various advantages provided by the 0.021" devices, along with various product launches and product approvals.
• Hospitals held the largest market share of around 70.79% in 2024. The growth of this segment can be attributed primarily to the increasing patient pool suffering from neurovascular disorders, such as ischemic & hemorrhagic stroke, brain aneurysm, Traumatic brain injury (TBI), and Arteriovenous Malformation (AVM).
• North America neurovascular devices dominated the market with a share of 27.62% in 2024 owing to the presence of key manufacturers such as Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit medical systems, Inc. in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Device
  • 1.2.2. Therapeutic Applications
  • 1.2.3. Size
  • 1.2.4. End Use
  • 1.2.5. Regional Scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Neurovascular Devices Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Prevalence of Neurovascular Diseases
    • 3.2.1.2. Technological Advancements In Neurovascular Devices
    • 3.2.1.3. Rising Number of Awareness Initiatives
    • 3.2.1.4. Increasing Demand For Minimally Invasive Procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Product Recalls
    • 3.2.2.2. High Treatment Cost Associated With Neurovascular Disorders
• 3.3. Neurovascular Devices Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Neurovascular Devices Market: Segment Analysis, By Device, 2018 - 2030 (USD Million and Volume Unit)

• 4.1. Definition and Scope
• 4.2. Device Market Share Analysis, 2024 & 2030
• 4.3. Global Neurovascular Devices Market, by Device, 2018 to 2030
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.4.1. Cerebral Embolization and Aneurysm coiling devices
    • 4.4.1.1. Cerebral embolization and aneurysm coiling devices market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.1.2. Embolic coils
      • 4.4.1.2.1. Embolic coils market, 2018 - 2030 (USD Million)
    • 4.4.1.3. Flow diverters
      • 4.4.1.3.1. Flow diverters market, 2018 - 2030 (USD Million)
    • 4.4.1.4. Liquid embolic agents
      • 4.4.1.4.1. Liquid embolic agents market, 2018 - 2030 (USD Million)
  • 4.4.2. Cerebral angioplasty and stenting sytems
    • 4.4.2.1. Cerebral angioplasty and stenting sytems market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.2.2. Carotid Artery Stents
      • 4.4.2.2.1. Carotid artery stents market, 2018 - 2030 (USD Million)
    • 4.4.2.3. Embolic Protection Devices
      • 4.4.2.3.1. Embolic protection systems devices market, 2018 - 2030 (USD Million)
  • 4.4.3. Neurothrombectomy devices
    • 4.4.3.1. Neurothrombectomy devices market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.3.2. Clot Retrieval Devices
      • 4.4.3.2.1. Clot retrieval devices market, 2018 - 2030 (USD Million)
    • 4.4.3.3. Suction Devices
      • 4.4.3.3.1. Suction devices market, 2018 - 2030 (USD Million)
    • 4.4.3.4. Vascular Snares
      • 4.4.3.4.1. Vascular snares market, 2018 - 2030 (USD Million)
  • 4.4.4. Support devices
    • 4.4.4.1. Support devices market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.4.2. Micro Catheters
      • 4.4.4.2.1. Micro catheters market, 2018 - 2030 (USD Million)
    • 4.4.4.3. Micro Guidewires
      • 4.4.4.3.1. Micro guidewires market, 2018 - 2030 (USD Million)
  • 4.4.5. Trans Radial Access Devices
    • 4.4.5.1. Trans radial access devices market, 2018 - 2030 (USD Million and Volume Unit)

Chapter 5. Neurovascular Devices Market: Segment Analysis, By Therapeutic Applications, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Therapeutic Applications Market Share Analysis, 2024 & 2030
• 5.3. Global Neurovascular Devices Market, by Therapeutic Applications, 2018 to 2030
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.4.1. Stroke
    • 5.4.1.1. Stroke market, 2018 - 2030 (USD Million)
  • 5.4.2. Cerebral artery stenosis
    • 5.4.2.1. Cerebral artery stenosis market, 2018 - 2030 (USD Million)
  • 5.4.3. Cerebral aneurysm
    • 5.4.3.1. Cerebral aneurysm market, 2018 - 2030 (USD Million)
    • 5.4.3.2. Aneurysmal Subarachnoid Hemorrhage
      • 5.4.3.2.1. Aneurysmal subarachnoid hemorrhage market, 2018 - 2030 (USD Million)
    • 5.4.3.3. Others
      • 5.4.3.3.1. Others market, 2018 - 2030 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Neurovascular Devices Market: Segment Analysis, By Size, 2018 - 2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. Size Market Share Analysis, 2024 & 2030
• 6.3. Global Neurovascular Devices Market, by Size, 2018 to 2030
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 6.4.1. 0.027"
    • 6.4.1.1. 0.027" market, 2018 - 2030 (USD Million)
  • 6.4.2. 0.021"
    • 6.4.2.1. 0.021" market, 2018 - 2030 (USD Million)
  • 6.4.3. 0.071"
    • 6.4.3.1. 0.071" market, 2018 - 2030 (USD Million)
  • 6.4.4. 0.017"
    • 6.4.4.1. 0.017" market, 2018 - 2030 (USD Million)
  • 6.4.5. 0.019"
    • 6.4.5.1. 0.019" market, 2018 - 2030 (USD Million)
  • 6.4.6. 0.013"
    • 6.4.6.1. 0.013" market, 2018 - 2030 (USD Million)
  • 6.4.7. 0.058"
    • 6.4.7.1. 0.058" market, 2018 - 2030 (USD Million)
  • 6.4.8. 0.068"
    • 6.4.8.1. 0.068" market, 2018 - 2030 (USD Million)
  • 6.4.9. Others
    • 6.4.9.1. Others market, 2018 - 2030 (USD Million)

Chapter 7. Neurovascular Devices Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 7.1. Definition and Scope
• 7.2. End Use Market Share Analysis, 2024 & 2030
• 7.3. Global Neurovascular Devices Market, by End Use, 2018 to 2030
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 7.4.1. Hospital
    • 7.4.1.1. Hospital market, 2018 - 2030 (USD Million)
  • 7.4.2. Specialty clinics
    • 7.4.2.1. Specialty clinics market, 2018 - 2030 (USD Million)
  • 7.4.3. Others
    • 7.4.3.1. Others market, 2018 - 2030 (USD Million)

Chapter 8. Neurovascular Devices Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. Mexico
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Recent Developments & Impact Analysis by Key Market Participants
• 9.3. Company Market Share Analysis, 2024
• 9.4. Key Company Profiles
  • 9.4.1. Medtronic
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Stryker Corporation
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Terumo Corporation
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Penumbra, Inc.
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Johnson & Johnson Services, Inc.
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Integra LifeSciences Corporation
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Acandis GmbH
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Spiegelberg GmbH & Co. KG
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. MicroPort Scientific Corporation
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives

관련자료